Explore Our Biomarker Menu

Biomarker:

KC-GRO

Biological or Clinical Significance:

Mouse KC (KC/GRO)—also known as CXCL1, GROα, neutrophil-activating protein 3 (NAP-3), and melanoma growth stimulating activity alpha (MGSA-α)—is a 10.2 kDa CXC chemokine. KC/GRO is produced by fibroblasts induced by platelet-derived growth factor and expressed in macrophages and endothelial cells. It produces a biological signal by binding to its receptor, CXCR2. During inflammation, it is involved in neutrophil activation and shows hematopoietic activity. Upon secretion from bone marrow stromal cells through proteolytic cleavage, the N-terminal processed form of KC (5-72) shows highly enhanced hematopoietic activity. This chemokine and its receptor are responsible for neutrophil chemotaxis in epidemic keratoconjunctivits.The Mouse KC/GRO Kit provides assay-specific components for the quantitative determination of endogenous KC/GRO in mouse urine, serum, plasma, and cell culture supernatants.

References:

Analyte:

KC-GRO

Matrix:

Mouse Serum

Status:

Experienced Running

Sensitivity-LLOQ:

1.98 pg/mL

Sensitivity-ULOQ:

7,200 pg/mL

platform

MSD-ECL

Required Sample Volume

25 µL/well

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.